NEJM· Jiayu Wang Huiping Li Fei Xu Tao Wu Zhongsheng Tong Jiuwei Cui Xujuan Wang Zhenchuan Song Tao Sun Huihui Li Weimin Xie Jing Sun Xueying Zhang Yuee Teng Xiaoping Li Jinhai Zhu Ting Luo Bing Zhao Fangling Ning Chunwei Xie Lu Gan Guobing Yin Yang Li Chunxiu Yuan Wei You Zhiyong Wu Qiang Liu Xiangshun Kong Jianying Chang Jiuda Zhao Zhenhua Zhai Quchang Ouyang Xinghua Han Fanfan Li Jianyun Nie Guohui Han Chongsheng Xia Wei Huang Silong Xiang Kai Zou Yulei Wang and Binghe Xu·· 5 小时前评分36
Anbenitamab 联合 HB1801 治疗 HER2 阳性晚期乳腺癌
Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer
导读
Anbenitamab 联合 HB1801 治疗 HER2 阳性晚期乳腺癌的研究由 NEJM 提前在线发表。所给正文仅标注“Ahead of Print”，未提供试验设计、样本量、疗效或安全性结果。
来源：NEJM · nejm.org